Advancing Eye Care Through Research
At Newsom Eye, we advance the field of eye care through rigorous research and participation in FDA studies. Our dedication to improving patient outcomes drives us to collaborate with leading researchers and institutions to investigate innovative treatments, technologies, and interventions.
How FDA Clinical Studies are Shaping Eye Care Innovation
We actively participate in FDA studies to provide the highest quality of care to our patients. These studies help us evaluate the safety and effectiveness of new medications, devices, and procedures before they are made widely available. Contributing to the development of groundbreaking therapies has the potential to transform the lives of individuals affected by various eye conditions.
Exploring Diverse FDA Studies in Ophthalmology
Our experienced physicians and researchers participate in a numerous FDA studies across ophthalmic subspecialties. From investigating treatments for retinal diseases to evaluating innovative surgical techniques for cataract and refractive surgery, we are at the forefront of cutting-edge research in ophthalmology.
Offering Patients Access to the Latest FDA – Approved Treatments
By participating in FDA studies, we offer patients access to the latest therapies and interventions. These treatments may not be available elsewhere, allowing us to provide the highest standard of care, based on the latest scientific evidence.
Commitment to Leading Ophthalmic Research and Excellence
We strive for excellence not only in clinical care, but in research, education, and innovation. Our participation in FDA studies contributes to the knowledge base of our profession and shapes the future of eye care.
Sharing Our FDA Studies
We are committed to transparency and patient-centered care,. Below, you’ll find information about some of the FDA studies in which we are currently involved. These studies represent just a portion of our ongoing research efforts aimed at improving patient outcomes and advancing the field of ophthalmology.
Past & Current FDA Studies Include:
- FDA Clinical Study for Segmented Bifocal Intraocular Lens, Lenstec, Inc
- FDA Clinical Study for the Light Adjustable Intraocular Lens, RxSight.
- FDA Clinical Study for EYEFILL Viscoelastic, Croma Pharmaceuticals, Inc
- FDA Clinical Study for Besivance Postoperative Cataract Retrospective Surveillance, Bausch & Lomb
- FDA Clinical Study for Besivance Postoperative LASIK Retrospective Surveillance, Bausch & Lomb
- FDA Clinical Study for Lenstec Softec HD Intraocular Lens, Lenstec, Inc.
- FDA Clinical Study for VISCO SHIELD Viscoelastic, OASIS Medical
- FDA Clinical Study for Extended Depth of Focus Intraocular Lens, Alcon Labs
- FDA Clinical Study for IC-8 Apthera small-aperture IOL, AcuFocus
- FDA Clinical Study for the SBL-3 Multifocal IOL, Lenstec